Pulmonary Antifibrotic Mechanisms Aspirin-Triggered Lipoxin A(4) Synthetic Analog

No successful therapies are available for pulmonary fibrosis, indicating the need for new treatments. Lipoxins and their 15-epimers, aspirin-triggered lipoxins (ATL), present potent antiinflammatory and proresolution effects (Martins et al., J Immunol 2009;182:5374–5381). We show that ATLa, an ATL s...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Respir Cell Mol Biol
Auteurs principaux: Guilherme, Rafael F., Xisto, Debora G., Kunkel, Steven L., Freire-de-Lima, Célio G., Rocco, Patricia R.M., Neves, Josiane S., Fierro, Iolanda M., Canetti, Claudio, Benjamim, Claudia F.
Format: Artigo
Langue:Inglês
Publié: American Thoracic Society 2013
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5459549/
https://ncbi.nlm.nih.gov/pubmed/23848293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2012-0462OC
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires